Free shipping on all orders over $ 500


Cat. No. M5286
Acrivastine Structure
Size Price Availability Quantity
10mg USD 70 In stock
50mg USD 240 In stock
Bulk Inquiry?

Quality Control
  • Current batch:
  • Purity >99%
  • COA
  • MSDS
Biological Activity

In peripheral histamine antagonism as measured by histamine-induced flares and wheals, acrivastine is equipotent to triprolidine and a 4 to 8 mg dose of acrivastine has been shown to be effective in allergic rhinitis. This means that there is considerable separation between the expected therapeutic dose and a dose at which central nervous system impairment might occur.

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Chemical Information
Molecular Weight 348.44
Formula C22H24N2O2
CAS Number 87848-99-5
Purity >99%
Solubility 10mM in DMSO
Storage at -20°C

Quantitative determination of acrivastine and pseudoephedrine hydrochloride in pharmaceutical formulation by high performance liquid chromatography and derivative spectrophotometry.
Altuntas TG, et al. J Pharm Biomed Anal. 1998 May;17(1):103-9. PMID: 9608432.

Terfenadine alters action potentials in isolated canine Purkinje fibers more than acrivastine.
Lang DG, et al. J Cardiovasc Pharmacol. 1993 Sep;22(3):438-42. PMID: 7504135.

Related EGFR/HER2 Products

Anlotinib is a EGFR inhibitor extracted from patent 2015185012 A1, compound 1,which can be used to treat non-small cell lung cancer.


Cetuximab, a novel molecular-targeted agent,is an inhibitor of EGFR monoclonal humanized antibody interacting with the extracellular binding site of EGFR to block ligand stimulation. MW : 145.781 KD.


EAI045 is an allosteric inhibitor that targets selected drug-resistant EGFR mutants but spares the wild-type receptor.

Gefitinib HCl

Gefitinib Hcl(ZD-1839 Hcl) is an EGFR inhibitor, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells. Therefore, it is only effective in cancers with mutated and overactive EGFR.


Erlotinib is an EGFR inhibitor with IC50 of 2 nM, >1000-fold more sensitive for EGFR than human c-Src or v-Abl.

Abmole Inhibitor Catalog 2017

Keywords: Acrivastine supplier, EGFR/HER2, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2017 AbMole BioScience. All Rights Reserved.